Making medicines evergreen

Andrew Hitchings, Emma Baker, and Teck Khong examine how drug companies maximise profits after patents expire and show why regulatory agencies, policy makers, and prescribers need to be alert to the use of these techniques

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2012-11, Vol.345 (7886), p.18-20
Hauptverfasser:	Hitchings, Andrew W, Baker, Emma H, Khong, Teck K
Format:	Artikel
Sprache:	eng
Schlagworte:	ANALYSIS Brand name drugs Brand names Brands Costs Dosage Drug Costs Drug Industry - organization & administration Drug prescriptions Drug Prescriptions - economics Drugs, Generic - economics Drugs, Generic - supply & distribution Evergreening Health economics Hospitals Humans Market shares Marketing Medical treatment Pharmaceutical industry Prescription drugs Primary care Primary health care Productivity Schizophrenia United Kingdom Writing tablets
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!